Sonnet BioTherapeutics Holdings, Inc. (SONN)
NASDAQ: SONN · IEX Real-Time Price · USD
0.265
+0.002 (0.65%)
At close: Jul 6, 2022 4:00 PM
0.253
-0.012 (-4.607%)
Pre-market:
Jul 7, 2022 5:12 AM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 - 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
|
0.48 | 0 | 0 | 30.73 | 41.43 | 41.7 | 35.35 | 29.84 | 8.25 | 6.85 | Upgrade
|
| Revenue Growth (YoY)
|
- | - | - | -25.82% | -0.65% | 17.96% | 18.46% | 261.85% | 20.36% | 364.05% | Upgrade
|
| Cost of Revenue
|
0 | 0 | 0 | 28.13 | 37.13 | 36.03 | 31.43 | 27.3 | 7.94 | 6.55 | Upgrade
|
| Gross Profit
|
0.48 | 0 | 0 | 2.61 | 4.31 | 5.67 | 3.92 | 2.55 | 0.31 | 0.31 | Upgrade
|
| Selling, General & Admin
|
8.94 | 7.53 | 2.51 | 3.86 | 4.55 | 5.8 | 6.8 | 5.98 | 4.23 | 2.31 | Upgrade
|
| Research & Development
|
16.63 | 9.88 | 2.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Operating Expenses
|
0 | 6.83 | 0 | 4.12 | 5 | 2.49 | 2.2 | 2.11 | 0.68 | 0.59 | Upgrade
|
| Operating Expenses
|
25.57 | 24.24 | 4.71 | 7.98 | 9.54 | 8.29 | 9 | 8.09 | 4.91 | 2.9 | Upgrade
|
| Operating Income
|
-25.09 | -24.24 | -4.71 | -5.37 | -5.24 | -2.62 | -5.08 | -5.54 | -4.61 | -2.59 | Upgrade
|
| Interest Expense / Income
|
0 | 0 | 0.16 | 2.55 | 2.59 | 2.35 | 3.47 | 2.28 | 0.76 | 0.47 | Upgrade
|
| Other Expense / Income
|
-0.1 | 0.03 | 0 | -0.36 | -0.39 | 3.91 | 3.4 | -0.95 | -0.19 | 0.08 | Upgrade
|
| Pretax Income
|
-24.98 | -24.27 | -4.87 | -7.56 | -7.44 | -8.88 | -11.95 | -6.88 | -5.17 | -3.15 | Upgrade
|
| Income Tax
|
0 | 0 | 0 | -0.7 | -0.64 | 0.2 | 0.19 | -0.48 | 0.04 | 0.02 | Upgrade
|
| Net Income
|
-24.98 | -24.27 | -4.87 | -6.85 | -6.79 | -9.08 | -12.14 | -6.4 | -5.21 | -3.17 | Upgrade
|
| Preferred Dividends
|
0 | 41.34 | 0 | 0.12 | 0.11 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income Common
|
-24.98 | -65.6 | -4.87 | -6.97 | -6.9 | -9.08 | -12.14 | -6.4 | -5.21 | -3.17 | Upgrade
|
| Shares Outstanding (Basic)
|
25 | 9 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted)
|
25 | 9 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change
|
160.57% | 76.14% | 3850.24% | 39.41% | 16.39% | 52.29% | 124.95% | 45.07% | 71.75% | 114.48% | Upgrade
|
| EPS (Basic)
|
-1.02 | -6.96 | -0.91 | -51.48 | -70.98 | -108.68 | -221.00 | -265.20 | -312.00 | -325.00 | Upgrade
|
| EPS (Diluted)
|
-1.02 | -6.96 | -0.91 | -51.48 | -70.98 | -108.68 | -221.00 | -265.20 | -312.00 | -325.00 | Upgrade
|
| Free Cash Flow Per Share
|
-0.92 | -1.67 | -0.42 | -20.74 | -19.45 | -20.27 | -128.66 | -123.05 | -378.94 | -363.37 | Upgrade
|
| Gross Margin
|
100.00% | - | - | 8.49% | 10.40% | 13.59% | 11.09% | 8.53% | 3.72% | 4.46% | Upgrade
|
| Operating Margin
|
-5187.36% | - | - | -17.47% | -12.64% | -6.28% | -14.37% | -18.58% | -55.85% | -37.82% | Upgrade
|
| Profit Margin
|
-5165.97% | - | - | -22.69% | -16.66% | -21.77% | -34.33% | -21.46% | -63.22% | -46.21% | Upgrade
|
| Free Cash Flow Margin
|
-4663.91% | - | - | -9.14% | -4.56% | -4.06% | -19.94% | -10.04% | -77.14% | -51.84% | Upgrade
|
| Effective Tax Rate
|
0.00% | 0.00% | 0.00% | 9.28% | 8.66% | -2.24% | -1.57% | 6.93% | -0.79% | -0.61% | Upgrade
|
| EBITDA
|
-24.89 | -24.21 | -4.71 | -3.19 | -2.56 | -4.19 | -6.78 | -3.01 | -3.79 | -2.29 | Upgrade
|
| EBITDA Margin
|
-5146.29% | - | - | -10.38% | -6.19% | -10.05% | -19.19% | -10.09% | -45.99% | -33.40% | Upgrade
|
| Depreciation & Amortization
|
0.1 | 0.06 | 0 | 1.82 | 2.28 | 2.34 | 1.7 | 1.59 | 0.62 | 0.38 | Upgrade
|
| EBIT
|
-24.98 | -24.27 | -4.71 | -5.01 | -4.85 | -6.53 | -8.48 | -4.6 | -4.42 | -2.67 | Upgrade
|
| EBIT Margin
|
-5165.97% | - | - | -16.29% | -11.70% | -15.66% | -23.99% | -15.41% | -53.54% | -39.00% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).